Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 501

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 501
---
ant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                                                                                                                                                                                                                                       |
| ​           | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 10.8

#       | ​ | Offer Letter by and between Jeffrey Larson, Ph.D., DABT and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.30 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                                                                                                                                                                                                                           |
| ​           | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 10.9

#       | ​ | Offer Letter by and between Yixin “Joseph” Chen, Ph.D. and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.31 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                                                                                                                                                                                                                            |
| ​           | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 10.10

#      | ​ | Offer Letter by and between Stephen O’Brien, MAcc, CPA and Tvardi Therapeutics, Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                  |
II-3

| Exhibit No. |   | Description                                                                                                                                                                                                                                                                                                                  |
| ​           | ​ | ​                                                                                                                                                                                                                                                                                                                            |
| 10.11

#      | ​ | Tvardi Therapeutics, Inc. 2018 Stock Incentive Plan, as amended (incorporated by reference from Exhibit 10.24 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                                                        |
| ​           | ​ | ​                                                                                                                                                                                                                                                                                                                            |
| 10.12

#      | ​ | Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Tvardi Therapeutics, Inc. 2018 Stock Incentive Plan (incorporated by reference from Exhibit 10.25 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).         |
| ​           | ​ | ​                                                                                                                                                                                                                                                                                                                            |
| 10.13

#